Benchmarks were higher on Tuesday following strong gains among commodity, consumer and airline stocks
Pharmaceutical giant Allergan looks poised to have a great year in 2017.
The restaurants and the biotechs tried their best to save us but it just wasn't enough, Cramer says.
AbbVie's buyout of Shire reduces taxes but also grows its drug pipeline and adds cash flow.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.